Eye cancer · Conditions

Retinoblastoma (Eye Cancer in Young Children): A Treatment Guide for Parents

Retinoblastoma is a cancer of the retina that affects babies and young children, almost always before age 5. The most common first sign is a white glow in the pupil, often seen first in a flash photo. When the cancer is found while it is still inside the eye, more than 95% of children survive in high-income countries. Chemotherapy given into the eye's artery or into the eye itself now saves many eyes that once had to be removed.
Where in the eyeRetina
Who it affects
babies and young children, almost all under 5
How common
about 1 in 15,000–20,000 births
Most common first sign
a white pupil (leukocoria), often seen in photos
Heritable form
about 4 in 10 children
3-year survival
99.5% in high-income countries
Order of priorities
life first, then the eye, then sight

A white glow in your child's pupil, or the word "retinoblastoma" from a doctor, is frightening. The most important fact comes first: when this cancer is found while it is still inside the eye, the great majority of children are cured. Treatment aims first to save your child's life and then, whenever it is safe, the eye and useful sight.

What is retinoblastoma?

Retinoblastoma is a cancer of the retina, the thin layer at the back of the eye that senses light. It starts when an immature retinal cell loses both working copies of a gene called RB1. This gene normally acts as a brake on cell division. Without the brake, the cell keeps dividing and forms a tumor.

A child can have one tumor or several, in one eye or in both. Tumors can shed small clumps of cells, called seeds, into the clear gel that fills the eye (the vitreous) or under the retina. Seeds are harder for treatment to reach. Without treatment, the cancer can grow along the optic nerve toward the brain or spread through the blood to the bones and bone marrow. That is why it is always treated promptly.

Cross-section of the eye and its surroundings, showing where the main eye tumors arise. 1 2 3 4 5 Eyelid Conjunctiva Cornea Iris Lens Ciliary body Sclera Retina Vitreous Choroid Optic nerve Orbit (eye socket) 1 · Uveal melanoma (iris, ciliary body, choroid) 2 · Retinoblastoma (retina, children) 3 · Conjunctival tumors (surface) 4 · Eyelid tumors 5 · Orbital tumors (behind the eye)
Figure Cross-section of the eye and its surroundings, showing where the main eye tumors arise.

Who gets retinoblastoma, and how common is it?

Retinoblastoma is rare: about 1 in 15,000–20,000 live births, or roughly 8,000–9,000 children worldwide each year. Boys and girls of all backgrounds are affected at similar rates. About two-thirds of children are diagnosed before their second birthday, and almost all before age 5. About 1 child in 3 has tumors in both eyes. These children are usually diagnosed earlier: at around 15 months on average, compared with about 24 months when one eye is affected.

Why does it matter whether retinoblastoma is heritable?

In the heritable form, the first RB1 change is present in every cell of the body (a germline variant). The American Cancer Society estimates that this applies to about 4 in 10 children. This group includes every child with tumors in both eyes and about 15% of children with one eye affected. Yet about 9 in 10 of these children are the first in their family to have the disease. In the non-heritable form, both changes occur only in the tumor cells of one eye.

Which form a child has shapes the screening of brothers and sisters, the choice of treatment (radiation is avoided whenever possible in the heritable form) and lifelong health checks. See retinoblastoma genetics and family screening.

What are the symptoms and signs of retinoblastoma?

Babies do not complain that they cannot see, and a child with one healthy eye can behave quite normally. So retinoblastoma is usually noticed by parents, relatives or a doctor:

  • A white pupil (leukocoria). In flash photos one pupil looks white or yellowish instead of red. In children under 5 this is the first sign in about 60%.
  • A squint (strabismus). One eye turns in or out, often because a tumor sits at the center of the retina. It is the first sign in about 20% of young children.
  • A red, painful or swollen eye without an obvious cause, a larger-looking eye, a change in iris color or, in advanced disease, a bulging eye.
  • Poor vision, noticed mainly in older children.
Flash Retina

Normal red reflex

Both pupils glow red or orange

Flash Pale tissue

White reflex (leukocoria)

One pupil glows white or yellow: see an eye doctor within days

Figure In a flash photo, light reflects from the back of the eye. The retina and the layer beneath it are rich in blood vessels, so the glow is normally red or orange. Something pale in the path of the light, such as a white tumor, a cloudy lens or scar tissue, turns the glow white or yellow.

A white pupil can also have other causes, such as a harmless reflection from the optic nerve, Coats disease or a cataract; see white pupil in photos. The American Academy of Pediatrics recommends checking the red reflex before a newborn leaves the hospital and at every well-child visit.

How is retinoblastoma diagnosed?

An ocular oncologist, a specialist in eye cancers such as retinoblastoma, makes the diagnosis from how the tumor looks and from imaging. Unlike most cancers, retinoblastoma is not biopsied: a needle could let cancer cells escape from the eye. Several tests map every tumor instead:

  • Examination under anesthesia. While your child sleeps under a short general anesthetic, both retinas are examined to their far edges. It is repeated during treatment to measure the response.
  • Wide-field photographs (for example with a RetCam camera) record each tumor and any seeds.
  • Ultrasound (B-scan) measures the tumor and shows calcium inside it, a finding regarded as essentially diagnostic.
  • Optical coherence tomography (OCT) shows the retina in cross-section. Hand-held OCT can reveal tiny tumors not yet visible and tell a tumor apart from harmless look-alikes.
  • MRI of the brain and eye sockets checks the optic nerve and the pineal gland in the brain. CT is avoided, because its radiation adds to the long-term cancer risk in the heritable form.

Every child should be offered RB1 genetic testing, usually from a blood sample. Bone marrow or spinal fluid tests are generally reserved for high-risk features or signs of spread. Prof. Dr. Elif Betül Türkoğlu has published research on OCT in retinoblastoma. Each test is explained on the page on how eye tumors are diagnosed.

How is retinoblastoma classified?

Two systems are used side by side. The group (A to E) describes the tumors inside the eye and shows how likely it is that the eye can be saved. The stage describes spread outside the eye and whether the child has the heritable form.

What do groups A to E mean?

Two closely related versions of the grouping exist, one from Los Angeles and one from Philadelphia. Some groups are worded differently, so check which version a report uses. The table follows the Philadelphia version.

Group What the specialist sees What it usually means
A Small tumors (3 mm or less) in the retina, away from the center of vision and the optic nerve Often treatable with laser or freezing alone
B Larger tumors in the retina, or tumors near the center of vision or the optic nerve, with only a little fluid under the retina Chemotherapy plus local treatment; a high chance of saving the eye
C Seeds close to the tumor (within 3 mm), in the vitreous or under the retina Chemotherapy plus local treatment, sometimes injections into the eye
D Seeds spread more widely (more than 3 mm from the tumor), or a very large tumor Intensive treatment; many eyes can still be saved
E Tumor filling more than half of the eye, or glaucoma from new blood vessels, bleeding or tumor at the front of the eye Removing the eye is often advised, especially if the other eye is healthy

What does the AJCC stage mean?

In the AJCC system of the American Joint Committee on Cancer, stages cT1 to cT3 mean tumors confined to the eye. Stage cT4 means tumor outside the eye, along the optic nerve or in the eye socket. An extra letter, H, records whether the child has the heritable form. In the Global Retinoblastoma Outcome Study, children with cT4 disease had about 9 times the risk of death of children with cT1 tumors. The page on eye cancer stages explains both systems in detail.

What are the goals of treatment?

Treatment follows a clear order: first save the child's life, then the eye, then as much sight as possible. A plan that keeps an eye but leaves a real risk of spread is not acceptable. That is why removing an eye is sometimes the safest choice, even when other options sound gentler.

Care is planned by a team: pediatric oncologists, interventional neuroradiologists, pediatric anesthesiologists, eye pathologists, geneticists and ocularists (who make artificial eyes) work with the ocular oncologist. Prof. Türkoğlu evaluates your child's case, explains the options and plans treatment with you. Where a method needs specialized facilities, such as intra-arterial chemotherapy, chemotherapy through a vein or radiotherapy, it is given together with the relevant specialist teams.

Which treatments are used for retinoblastoma today?

Most children receive a combination of treatments, chosen for each eye separately.

Treatment How it is given Mainly used for Key points
Intra-arterial chemotherapy Through a catheter into the eye's artery, under general anesthesia Advanced disease in one eye; recurrences; increasingly, earlier groups A high drug dose reaches the eye; given with interventional neuroradiology
Intravitreal chemotherapy A tiny injection into the vitreous Seeds in the vitreous Special safety technique; repeated about every 7–10 days
Intracameral chemotherapy An injection into the front chamber of the eye Seeds in the front chamber Newer method; small case series only
Chemotherapy through a vein In cycles, through a vein Both eyes; very young babies; high-risk findings in a removed eye; spread Given by pediatric oncologists; combined with local treatment
Laser, heat, freezing During an examination under anesthesia Small tumors; finishing treatment after chemotherapy Direct, local treatment
Plaque brachytherapy A temporary radioactive disc on the eye wall A single medium-sized tumor; recurrences Planned with radiation oncology and physics
External beam radiotherapy Radiation from outside the eye Resistant disease; spread outside the eye Avoided when possible: raises the risk of second cancers
Removal of the eye (enucleation) The eye is removed and an implant placed Group E and other high-risk eyes Often curative; the examined eye guides further treatment

Intra-arterial chemotherapy. A very thin tube (catheter) is guided from the groin to the ophthalmic artery, which supplies the eye, and chemotherapy (usually melphalan) is infused into it. The method grew out of work in Tokyo in the late 1980s. It is now a main treatment for advanced disease in one eye, given under general anesthesia by an interventional neuroradiology team.

Intravitreal chemotherapy. A tiny dose of melphalan or topotecan is injected into the vitreous to treat seeds. The entry site is frozen as the needle comes out, so that tumor cells cannot escape. For seeds in the front chamber of the eye, injections there (intracameral chemotherapy) are a newer option.

Chemotherapy through a vein (chemoreduction). Vincristine, etoposide and carboplatin, given for up to 6 cycles, shrink tumors in both eyes at once. Pediatric oncologists give it when both eyes are affected, for very young babies, when a removed eye shows high-risk features and when the cancer has spread outside the eye.

Laser, heat and freezing. Laser and transpupillary thermotherapy (a gentle heat laser) treat small tumors at the back of the eye; cryotherapy freezes those toward the front. They also finish off tumors shrunk by chemotherapy.

Radiation. In plaque brachytherapy, a small radioactive disc is stitched temporarily to the eye wall to treat a single medium-sized tumor or a recurrence. External beam radiotherapy is avoided whenever possible. In the heritable form it more than triples the risk of later cancers, especially when given in the first year of life. It can also affect the growth of the bones around the eye.

Removing the eye (enucleation). For eyes with very advanced disease (usually group E), removal is often the safest cure, particularly when the other eye is healthy. The eye is removed whole with about 10 mm of optic nerve, and an implant is placed. If the pathologist finds high-risk features, such as tumor in the optic nerve behind the eye wall, about 6 months of chemotherapy lowers the risk of spread. See enucleation and the artificial eye.

Each form of chemotherapy is explained on the page on intra-arterial and intravitreal chemotherapy.

What is the retinoblastoma survival rate, and can the eye be saved?

Survival depends above all on how early the cancer is found. According to the American Cancer Society, more than 9 in 10 children with retinoblastoma in the United States are cured. When the tumor is still inside the eye, 5-year survival is above 95%. It falls to about 60–90% after spread to the eye socket or nearby lymph nodes, and below 20% once the cancer reaches the brain or spinal fluid.

Where a child lives matters too. The Global Retinoblastoma Outcome Study followed 4,064 children from 149 countries who were diagnosed in 2017:

Country income group 3-year survival
High income 99.5%
Upper-middle income 91.2%
Lower-middle income 80.3%
Low income 57.3%

The gap mainly reflects late diagnosis: the cancer had already spread outside the eye in 42.9% of children in low-income countries, compared with 0.8% in high-income countries.

How often can the eye be saved?

  • At Wills Eye Hospital in Philadelphia, intra-arterial chemotherapy saved 74% of 341 eyes at 5 years. As the first treatment, it saved all group B and C eyes, 86% of group D and 55% of group E eyes. There was no metastasis or death in the series.
  • In a long-term Tokyo series (408 eyes, 1988–2007), 5-year eye salvage ranged from 100% in group A to 30% in group E. Many of these eyes also had radiotherapy.
  • A Cochrane review published in 2026 pooled six studies of advanced disease in one eye. Compared with chemotherapy through a vein, intra-arterial chemotherapy probably roughly doubles the chance of keeping the eye without progression at 2 years, with similar survival.
  • Without external radiotherapy, about 78% of eyes with seeds close to the tumor were saved at 5 years, compared with 49% of eyes with widespread seeds. Intravitreal chemotherapy now controls seeds in the vitreous in most eyes.

Sight depends on where the tumors lie. A tumor in the macula, the center of the retina, can limit sight even after a cure, while tumors farther out may leave vision largely intact.

What is trilateral retinoblastoma?

About 5% of children with the heritable form develop a related tumor in the middle of the brain, usually in the pineal region; older studies reported up to 15%. It appears most often between about 20 and 36 months of age. Five-year survival is about 67% when it is found early and 11% when it is found late. Some centers therefore do a brain MRI every 6 months for 5 years; practice varies.

What follow-up is needed after treatment?

In the first years after treatment, examinations under anesthesia take place about every 6–8 weeks until around age 3. This way, any regrowth or new tumor can be treated while it is small.

For survivors of the heritable form, the main long-term risk is a second cancer: a bone tumor (osteosarcoma), a soft-tissue sarcoma, melanoma or a brain tumor, sometimes decades later. In high-income countries, these cancers and trilateral retinoblastoma have replaced metastasis as the main causes of death among survivors. The American Academy of Ophthalmology cites a risk of about 25% within 50 years, even without radiotherapy. External beam radiotherapy more than triples it, so unnecessary radiation is avoided and MRI is used instead of CT.

Survivorship care also includes hearing tests after carboplatin, kidney and nerve checks after chemotherapy, and fertility counseling. In survivors of the heritable form, persistent bone pain or a new lump needs a prompt check. Keep a written summary of the diagnosis, the genetic result and all treatments.

Retinoblastoma treatment in Turkey: what families from abroad can expect

If you are considering retinoblastoma treatment abroad, the first step needs no travel: send your child's photographs, scans and reports for a remote second opinion. The reply explains what the findings show, whether the proposed plan seems appropriate and whether a visit to Antalya makes sense. It cannot replace an examination under anesthesia when decisions depend on the exact appearance of the tumors.

The first visit. Most young children need an examination under anesthesia soon after arrival. Your child must not eat or drink for several hours beforehand, as the anesthesia team instructs. A parent can usually stay until the anesthetic begins and rejoin the child in the recovery area. Afterward, Prof. Türkoğlu explains the findings and options in plain language.

Several visits. Retinoblastoma is rarely treated in a single trip. Intra-arterial chemotherapy sessions are a few weeks apart, injections into the eye roughly weekly, and chemotherapy through a vein runs over months. Some care, such as blood tests during chemotherapy, may be shared with your doctors at home when that is safe.

Travel. Antalya Airport is about 20–30 minutes by car from the practice. See the pages for international patients and on eye cancer treatment costs in Turkey.

BergemHealth

Traveling from abroad?

BergemHealth, the practice's international patient coordination partner in Antalya, can arrange airport transfers, accommodation near the clinic and appointment scheduling. If needed, it also provides an interpreter and a personal escort who speak Russian and Ukrainian. All medical decisions are made by Prof. Türkoğlu.

BergemHealth is a licensed travel agency in Antalya (TÜRSAB license A-8469).

Frequently asked questions

Is retinoblastoma curable?

Yes, in most children. When the cancer is found while it is still inside the eye, more than 95% of children survive in high-income countries. Results are much poorer when the tumor has already spread outside the eye. That is why a white pupil or a new squint in a young child should be checked within days.

Will my child lose the eye?

Not necessarily. Many eyes that once would have been removed are now saved with intra-arterial or intravitreal chemotherapy, combined with laser or freezing. In one large series, intra-arterial chemotherapy as the first treatment saved all group B and C eyes and 86% of group D eyes. For eyes with very advanced disease, especially when the other eye is healthy, removal is often the safest cure.

Will my child be able to see?

That depends mainly on where the tumors are. Tumors away from the macula, the center of the retina, often leave good sight. A tumor at the center can reduce central vision even after successful treatment. A child who keeps one healthy eye can develop normally, and checks after treatment also look for problems such as cataract.

Is retinoblastoma inherited, and could my other children get it?

About 4 in 10 children have the heritable form, including all children with tumors in both eyes. Yet most of them are the first in their family. A blood test shows whether an RB1 variant is present. If it is, brothers and sisters can be tested, and they are examined regularly from birth until their result is known. See the page on retinoblastoma genetics.

Why is no biopsy taken?

Because a needle in a retinoblastoma could let tumor cells escape from the eye. The diagnosis is reliable without tissue: the appearance on examination, wide-field photographs, ultrasound showing calcium in the tumor, OCT and MRI are characteristic. If an eye is removed, an eye pathologist examines the whole eye.

Why are CT scans and radiotherapy avoided?

Because children with the heritable form carry an RB1 change in every cell, and radiation raises their risk of later cancers such as sarcomas. External beam radiotherapy more than triples this risk. So MRI, which uses no radiation, replaces CT, and external radiotherapy is reserved for cancers that resist other treatment or have spread outside the eye.

How long will we need to stay in Antalya?

It depends on the treatment plan. The examination under anesthesia and the discussion of its results are arranged close together. Treatment itself usually means repeated sessions over weeks or months, so expect several visits or a longer stay. After reviewing your child's records, the practice can suggest a realistic schedule before you book travel.

Can retinoblastoma come back after treatment?

Yes, and that is why checks are so frequent. Treated tumors can grow again, and seeds can reappear. In the heritable form, new tumors can develop in either eye during early childhood. Regular examinations under anesthesia are designed to find a recurrence while it is still small and treatable; the gaps between them grow as the child gets older.

References

  1. National Cancer Institute. Retinoblastoma Treatment (PDQ®)–Health Professional Version. cancer.gov, updated 2025. cancer.gov
  2. GeneReviews®. Retinoblastoma. NCBI Bookshelf. ncbi.nlm.nih.gov
  3. EyeWiki, American Academy of Ophthalmology. Retinoblastoma. Includes the 2026 Cochrane review findings. eyewiki.org
  4. American Academy of Ophthalmology. [Retinoblastoma: presentation, genetics and outcomes — education topic, European perspective]. aao.org
  5. American Cancer Society. Key Statistics for Retinoblastoma. cancer.org
  6. American Cancer Society. [Survival rates for retinoblastoma]. cancer.org
  7. Global Retinoblastoma Study Group. [Global Retinoblastoma Outcome Study: 4,064 children from 149 countries]. Lancet Global Health, 2022. sciencedirect.com
  8. Shields CL, et al. [Intra-arterial chemotherapy for retinoblastoma in 341 eyes (1,292 infusions) at Wills Eye Hospital]. Journal of AAPOS, 2021. sciencedirect.com
  9. Suzuki S, et al. [Long-term results of selective ophthalmic arterial infusion in 343 children (408 eyes) treated in Tokyo, 1988–2007]. Ophthalmology, 2011. sciencedirect.com
  10. StatPearls. [Retinoblastoma: clinical overview]. NCBI Bookshelf. ncbi.nlm.nih.gov
  11. Turkoglu EB, Erol MK, Karaca BO. Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand-held optical coherence tomography. Photodiagnosis and Photodynamic Therapy, 2021;34:102331. PubMed
  12. Turkoglu EB, Erol MK. Optical coherence tomography findings in a case with cavitary retinoblastoma. Journal Français d'Ophtalmologie, 2021;44(2):e97-e98. PubMed

Need an ocular oncology opinion?

Send your scans and reports for a review by Prof. Türkoğlu, or book a consultation in Antalya. Adults and children are seen.

Send a request